EFSA Reaffirms Aspartame Safety, Consumer Groups Dispute

EFSA has re-evaluated aspartame and upheld existing acceptable daily intake limits, three years after WHO's IARC classified it as 'possibly carcinogenic'. Consumer organizations question the decision, citing potential conflicts of interest and long-term health risks. The reaffirmation maintains regulatory status quo in Europe, but the controversy persists.